Loading clinical trials...
Loading clinical trials...
Clinical Validation Study of Point of Care Kenota 1 System and Total Immunoglobulin E Test Kit Using the CWS Method Comparison Validation Study
Conditions
Interventions
Total Immunoglobulin E, Obtained From Fingerstick Sample
Locations
3
United States
St. Paul Allergy & Asthma
Saint Paul, Minnesota, United States
Allergy Partners of Chapel Hill
Chapel Hill, North Carolina, United States
Children's Specialty Group
Virginia Beach, Virginia, United States
Start Date
January 27, 2023
Primary Completion Date
April 7, 2023
Completion Date
April 7, 2023
Last Updated
May 6, 2023
NCT06406114
NCT04828603
NCT06993103
NCT06633250
NCT06771440
NCT04259359
Lead Sponsor
Kenota Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions